21 reports of this reaction
3.9% of all ESMOLOL HYDROCHLORIDE reports
#2 most reported adverse reaction
CARDIAC ARREST is the #2 most commonly reported adverse reaction for ESMOLOL HYDROCHLORIDE, manufactured by Baxter Healthcare Corporation. There are 21 FDA adverse event reports linking ESMOLOL HYDROCHLORIDE to CARDIAC ARREST. This represents approximately 3.9% of all 539 adverse event reports for this drug.
Patients taking ESMOLOL HYDROCHLORIDE who experience cardiac arrest should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CARDIAC ARREST is moderately reported among ESMOLOL HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to cardiac arrest, the following adverse reactions have been reported for ESMOLOL HYDROCHLORIDE:
The following drugs have also been linked to cardiac arrest in FDA adverse event reports:
CARDIAC ARREST has been reported as an adverse event in 21 FDA reports for ESMOLOL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CARDIAC ARREST accounts for approximately 3.9% of all adverse event reports for ESMOLOL HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience cardiac arrest while taking ESMOLOL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.